Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Change in Account Payables (2024 - 2025)

Biofrontera has reported Change in Account Payables over the past 2 years, most recently at $3.4 million for Q4 2025.

  • Quarterly results put Change in Account Payables at $3.4 million for Q4 2025, up 2062.57% from a year ago — trailing twelve months through Dec 2025 was -$2000.0 (up 99.86% YoY), and the annual figure for FY2025 was -$2000.0, up 99.86%.
  • Change in Account Payables for Q4 2025 was $3.4 million at Biofrontera, up from $1.3 million in the prior quarter.
  • Over the last five years, Change in Account Payables for BFRIW hit a ceiling of $3.4 million in Q4 2025 and a floor of -$6.1 million in Q2 2025.